Met Life Investment Management, LLC Aerie Pharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

41 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 10, 2024	BUY	$6.37 - $15.23 $29,244 - $69,920	4,591 Added 23.34%	24,261 $367,000
Q3 2022 Jun 14, 2023	BUY	$6.37 - $15.23 $154,542 - $369,495	24,261 New	24,261 $367,000
Q3 2022 Mar 22, 2023	BUY	$6.37 - $15.23 $29,244 - $69,920	4,591 Added 23.34%	24,261 $367,000
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $29,244 - $69,920	4,591 Added 23.34%	24,261 $367,000
Q2 2022 May 10, 2024	SELL	$4.95 - $9.16 $22,750 - $42,099	-4,596 Reduced 18.94%	19,670 $147,000
Q2 2022 Jun 20, 2023	BUY	$4.95 - $9.16 $97,366 - $180,177	19,670 New	19,670 $147,000
Q2 2022 Mar 22, 2023	SELL	$4.95 - $9.16 $22,750 - $42,099	-4,596 Reduced 18.94%	19,670 $147,000
Q2 2022 Aug 11, 2022	SELL	$4.95 - $9.16 $22,750 - $42,099	-4,596 Reduced 18.94%	19,670 $148,000
Q1 2022 May 10, 2024	BUY	$5.64 - $9.8 $136,860 - $237,806	24,266 New	24,266 $220,000
Q1 2022 Jun 20, 2023	BUY	$5.64 - $9.8 $136,860 - $237,806	24,266 New	24,266 $220,000
Q1 2022 Mar 22, 2023	BUY	$5.64 - $9.8 $50,765 - $88,209	9,001 Added 58.96%	24,266 $220,000
Q1 2022 May 12, 2022	BUY	$5.64 - $9.8 $50,765 - $88,209	9,001 Added 58.96%	24,266 $221,000
Q4 2021 Jun 21, 2023	BUY	$7.02 - $13.33 $107,160 - $203,482	15,265 New	15,265 $107,000
Q3 2021 Jun 21, 2023	BUY	$11.32 - $16.63 $172,799 - $253,856	15,265 New	15,265 $174,000
Q2 2021 Jun 21, 2023	BUY	$15.16 - $18.97 $231,417 - $289,577	15,265 New	15,265 $244,000
Q1 2021 May 17, 2024	BUY	$13.12 - $20.9 $200,276 - $319,038	15,265 New	15,265 $272,000
Q1 2021 Jun 26, 2023	BUY	$13.12 - $20.9 $200,276 - $319,038	15,265 New	15,265 $273 Million
Q1 2021 Mar 22, 2023	SELL	$13.12 - $20.9 $15,389 - $24,515	-1,173 Reduced 7.14%	15,265 $272,000
Q1 2021 May 14, 2021	SELL	$13.12 - $20.9 $15,389 - $24,515	-1,173 Reduced 7.14%	15,265 $273,000
Q4 2020 May 24, 2024	SELL	$9.12 - $14.49 $27,378 - $43,498	-3,002 Reduced 15.44%	16,438 $222,000
Q4 2020 Jun 22, 2023	BUY	$9.12 - $14.49 $149,914 - $238,186	16,438 New	16,438 $222,000
Q4 2020 Mar 22, 2023	SELL	$9.12 - $14.49 $27,378 - $43,498	-3,002 Reduced 15.44%	16,438 $222,000
Q4 2020 Feb 16, 2021	SELL	$9.12 - $14.49 $27,378 - $43,498	-3,002 Reduced 15.44%	16,438 $222,000
Q3 2020 Jun 26, 2023	BUY	$10.46 - $14.46 $203,342 - $281,102	19,440 New	19,440 $228,000
Q2 2020 May 24, 2024	BUY	$12.0 - $16.13 $233,280 - $313,567	19,440 New	19,440 $287 Million
Q2 2020 Jun 26, 2023	BUY	$12.0 - $16.13 $233,280 - $313,567	19,440 New	19,440 $286,000
Q1 2020 Jul 12, 2023	BUY	$11.84 - $25.52 $230,169 - $496,108	19,440 New	19,440 $262,000
Q4 2019 Jul 12, 2023	BUY	$17.72 - $25.1 $344,476 - $487,944	19,440 New	19,440 $469,000
Q3 2019 Jul 12, 2023	BUY	$18.41 - $28.0 $357,890 - $544,320	19,440 New	19,440 $373,000
Q3 2019 Mar 22, 2023	BUY	$18.41 - $28.0 $56,113 - $85,344	3,048 Added 18.59%	19,440 $373,000
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $56,113 - $85,344	3,048 Added 18.59%	19,440 $374,000
Q2 2019 Jul 12, 2023	BUY	$28.97 - $48.21 $563,176 - $937,202	19,440 New	19,440 $574,000
Q1 2019 Jul 13, 2023	BUY	$36.32 - $49.25 $595,357 - $807,306	16,392 New	16,392 $778,000
Q4 2018 Jul 13, 2023	BUY	$33.0 - $60.04 $540,936 - $984,175	16,392 New	16,392 $591,000
Q4 2018 Mar 22, 2023	SELL	$33.0 - $60.04 $298,353 - $542,821	-9,041 Reduced 35.55%	16,392 $591,000
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $298,353 - $542,821	-9,041 Reduced 35.55%	16,392 $592,000
Q3 2018 Jul 13, 2023	BUY	$56.15 - $73.9 $920,410 - $1.21 Million	16,392 New	16,392 $1.01 Million
Q3 2018 Mar 22, 2023	BUY	$56.15 - $73.9 $1.43 Million - $1.88 Million	25,433 New	25,433 $1.57 Million
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $507,652 - $668,129	9,041 Added 55.15%	25,433 $1.57 Million
Q2 2018 Aug 15, 2018	BUY	$47.85 - $70.45 $51,008 - $75,099	1,066 Added 6.96%	16,392 $1.11 Million
Q4 2017 Feb 15, 2018	BUY	$50.85 - $65.1 $779,327 - $997,722	15,326	15,326 $916,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account